I’m considering TREMFYA®

As someone who is considering TREMFYA® for their moderate to severe plaque psoriasis, here’s some information you may find valuable when talking to your dermatologist and making your treatment decision together.

Your confident
conversation starts here

TALKING TO YOUR DERMATOLOGIST

TREMFYA® is the first FDA-approved medication of its kind to selectively block interleukin-23 (IL-23) for adults with moderate to severe plaque psoriasis

LEARN MORE ABOUT TREMFYA®

Curious how TREMFYA® performed in clinical trials?

UNCOVER RESULTS